Skip to content

Enhancing Peri-Implant Soft Tissue: A Study on Porcine-Derived Acellular Dermal Matrix

Comparative evaluation of the peri-implant soft tissue phenotype with and without the use of porcine-derived acellular dermal matrix A randomised control trial. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084503
Enrollment
24
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified

Interventions

Intervention1: ACELLULAR DERMAL MATRIX: Following local anesthesia, a mid-crestal incision is made, and full-thickness mucoperiosteal flaps are reflected to expose the bone. After osteotomy, the impla

Sponsors

chandan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.periodontaly healthy or with stable treated periodontitis and good oral hygiene(full mouth plaque score and full mouth bleeding score less than or equal to 10%) 2. need for one or two implants in the posterior region (maximum of three missing teeth). 3. enough bone avilability to place an implant with a minimum diameter of 3.8 to 4.2 mm and atleast 10mm length. 4. non-smoker. 5. ability to understand the study procedures and to comply with them to the entire length of the study.

Exclusion criteria

Exclusion criteria: 1.subjectes taking medications with immunosuppressors, bisphosphonates or high doses of corticosteroids; current drug or alcohol use or dependence that could interfere with adherence to study requirements. 2.pregnant or lactating women. 3.history of cancer requiring radiotherapy or chemotherapy during the last 5 years. 4.local inflammation (including untreated periodontitis) 5.severe bruxism or clenching habits. 6.any kind of bone augmentation performed on the implant site, with a healing period less than 6 months. 7.lack of primary implant stability assessed intra surgically.

Design outcomes

Primary

MeasureTime frame
increased peri-implant soft tissue thickness and width of keratinized mucosaTimepoint: baseline, 1month, 3months, 6months, 9months.

Secondary

MeasureTime frame
improved peri-implant soft tissue health and aesthetics. also longevity of implantTimepoint: baseline, 1month, 3months, 6months, 9months.

Countries

India

Contacts

Public ContactDR NANDINI MANJUNATH

A.J Institute of Dental Sciences.

nandinimanjunath747@gmail.com9845314069

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026